InferSens secures £870k scale-up capital for AI CleanTech play
InferSens, an AI and machine learning liquid sensor business which combats water-borne disease, has won crucial growth funding as it scales commercially from its Cambridge base.
Located at The Bradfield Centre at Cambridge Science Park, InferSens effectively monitors risk of Legionella in water systems.
RO Capital Partners in Hertfordshire has led an oversubscribed investment round alongside the Oxford Innovation Fund and Bruce Melizan, former MD of Interserve’s support services division.
ROCP’s contribution comprises £309,000 of the total £870,000 raised, which will be used as growth capital and to bring the product to market.
InferSens can non-invasively monitor the flow of any liquid in pipes and has made large strides in bringing down cost. The technology involves a small sensor which is installed on a pipe.
The business is of particular interest to building owners who are legally required to scrutinise the flow of water in properties for Legionella, with a fixed monthly fee charged per sensor.
Historically, checking for Legionella has involved the manual monitoring of water outlets – a laborious and environmentally wasteful process.
InferSens’ product can be deployed on any sized pipe, including national infrastructure, providing a clear growth path for the business, and neatly intersects machine learning, the Internet of Things, and CleanTech.
The ability to cut down on the manual testing of flow in pipes massively reduces the scope for waste, meaning that the technology will significantly boost environmental and sustainability scores for its users.
Edward Rowlandson, Group Managing Director, the RO, said: “As owners of a diverse and large property portfolio, InferSens immediately stood out. We are excited to invest in the business and its first class management team to bring a product to market which we believe will transform facilities management and for which we can see a number of wider applications, setting new levels of environmental efficiency and waste reduction.”
Colin Payne, CEO of InferSens, added: “I am delighted that InferSens has been oversubscribed for its funding round; a real recognition of our cutting edge technology at the interface of IoT sensing and on-device machine learning.
“This critical milestone for the business will enable the commercial launch of our ML-powered flow and temperature sensing technology, initially targeting the major global challenge of keeping buildings safe from Legionella.
“We have been fortunate to attract a stellar mix of engaged investors including experts in the fields of mobile communications, property development, facilities management, corporate finance, and tech start-ups, who are eager to work with us to help us achieve our ambitious goals.”